BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 15, 2018
View Archived Issues
Avillion enters agreement to develop PT-027 for asthma
Read More
First patient dosed in phase I study of Affibody's ABY-039
Read More
Merus said that Ono Pharmaceutical enter new research and license agreement
Read More
IL-32 isoforms tied to cardiovascular disease in HIV-infected individuals
Read More
Inovio Pharmaceuticals reports interim results from phase I study of DNA immunotherapy for HBV
Read More
FDA accepts IND for phase II study of SM-88 in pancreatic cancer
Read More
Jupiter Orphan Therapeutics submits IND in U.S. for Jotrol
Read More
Initiation of phase I trial to evaluate VLA-1553 vaccine candidate against Chikungunya
Read More
Savara begins OPTIMA study of Molgradex, ceases development of Aironite
Read More
OxThera initiates phase III study of Oxabact in primary hyperoxaluria
Read More
3BNC117 and 10-1074 antibody combination shows promise for HIV infection
Read More
Ionis opens enrollment in phase II trial of IONIS-FB-LRX in GA secondary to AMD
Read More
ImmunoRestoration enters license agreement with University of Pennsylvania
Read More
Medshine Discovery patents new PDE4 inhibitors
Read More
Arrowhead initiates phase I/IIa trial of ARO-HBV for hepatitis B
Read More
FDA accepts sBLA for Xeomin
Read More
Interim ANNEXA-4 data show high rate of hemostasis with andexanet alfa
Read More
Nanchang Helioeast Pharmaceutical presents novel TKIs
Read More
FDA places clinical hold on phase I/II trial of SGT-001 for Duchenne muscular dystrophy
Read More
CSL Behring studies safety of CSL-730 in healthy Caucasian and Japanese subjects
Read More
Japanese researchers disclose PDE7 inhibitors
Read More
FDA awards fast track designation to Destiny Pharma's exeporfinium chloride
Read More
University of Michigan discovers Bcr-Abl kinase inhibitors
Read More
3M Innovative Properties cytokine-production inducers
Read More
Exosome Diagnostics collaborates with Intezyne on assay for use in IT-139 trials
Read More
Novel AC5 inhibitor for treating myocardial infarction shows promise
Read More